Global Respiratory Partnering 2012-2018: Deal trends, players and financials

Global Respiratory Partnering 2012 to 2018 provides the full collection of Respiratory disease deals signed between the world’s pharmaceutical and biotechnology companies since 2012. The report presents financial deal terms values for Respiratory deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.